About Endospan

Endospan brings together a seasoned team of researchers, engineers and executives in the MedTech field. Backed by leading global venture groups, Endospan is focused on becoming a dominant competitor in the endovascular aortic repair market.

The Endospan platform is innovative, opening up options for repairing aneurysms and dissections in patients with anatomy previously unsuitable for endovascular therapy. The novel design of Endospan’s systems presents a true advancement when compared to traditional EVAR/TEVAR systems, enhancing endografts with gold-standard material durability, intra-procedural stability, and a shorter, simpler and less-invasive procedure.

Our Leadership

KEVIN MAYBERRY
Chief Executive Officer

Former Endologix executive with 14 years experience in R&D and global sales management demonstrating technical, sales, and marketing expertise. Innovative leader of R&D teams from concept through CE mark and IDE studies on multiple PMA products.

Click Here For Profile

Ami Katz
General Manager IL and
Vice President of Operations

Ami Katz has over 15 years of experience in operation management, production and product management, 7 of which are in the medical field. Prior to Endospan, Ami Katz held several VP of Operations roles and led start up companies from R&D to commercial phases (CE and FDA).

Ian McDougall
Vice President
Research & Development

Ian McDougall has over 20 years experience in leading teams that took products from concept, through clinical trial, and market approval in the interventional cardiology, cardiac surgery, and neurovascular fields. Prior to Endospan, Ian held director of engineering and executive roles at Aegis Innovation, Neovasc Inc., and Evasc Medical.

Pieter Buyl
Vice President,

Sales and Marketing

Pieter Buyl has over 25 years of experience in interventional cardiology, vascular and cardiac surgery markets. Prior to Endospan, Pieter held various international sales and marketing positions at Tryton Medical,

St. Jude Medical and Boston Scientific. At Tryton Medical, a start-up company, Pieter led the sales and marketing efforts from CE mark to FDA approval including US launch.

Jessica Kleine
Vice President of Clinical Affairs

Jessica Kleine joined Endospan in January 2020, giving additional depth to what was already an exciting team. She brings with her a wealth of experience in clinical research, having numerous leadership roles in diverse fields which have included the novel TENDYNE transcatheter mitral valve, devices for the treatment of peripheral artery disses, dysfunctional dialysis access, limb salvage and over 13 years of experience with class III coronary devices.

Liat Barziv
Vice President Finance

Liat Barziv has over 20 years of experience in financial management in both Start-up and Global Public companies. Prior to Endospan, Liat served as a CFO at Angog, a high-tech Start-up. Before that Liat served for more than a decade in Senior Financial Management positions with Teva Pharmaceutical (NASDAQ: teva). Earlier in her career, Liat served as CFO and Business development manager at ISS Israel. Liat is a Certified Public Accountant (CPA) in Israel, holds a BA in accounting and economics from Haifa University and LLM law degree from Bar Ilan University.

footer_bg_edited.jpg
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

©2020 by Endospan. 

Maskit St. 4

Herzlia Business Park

Herzlia, ISRAEL 46733

Privacy Policy